Marvell Technology, Inc.MRV.TO

Miravo Healthcare (formerly Nuvo Pharmaceuticals, est. 1983) develops and distributes prescription and non-prescription medical solutions across pain management, allergies, neurology, and dermatology. Operating globally from Mississauga, Canada, its business spans commercial sales, production, and licensing. Key products include Blexten (allergies), Cambia and Suvexx (migraines), Pennsaid and Vimovo (arthritis), NeoVisc (osteoarthritis), Soriatane (psoriasis), and various treatments for lice, GI health, and pain.